The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007

Annals of Internal Medicine

Volumn 156, Issue 4, 2012, Pages 271-278

  Ly, Kathleen N ^a   Xing, Jian ^a   Monina Klevens, R ^a   Jiles, Ruth B ^a   Ward, John W ^a   Holmberg, Scott D ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ADOLESCENT; ADULT; AGED; ARTICLE; ASIAN; CAUSE OF DEATH; CHILD; CHRONIC LIVER DISEASE; COMORBIDITY; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; MINORITY GROUP; MIXED INFECTION; MORTALITY; PACIFIC ISLANDER; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; UNITED STATES;

EID: 84857144025     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-156-4-201202210-00004     Document Type: Article

References (39)

1. Xu J, Kochanek KD, Murphy SL, Tejada-Vera B. Deaths: final data for 2007. Natl Vit Stat Rep. 2010;58:1-136.
2. American Cancer Society. Cancer Facts and Figure 2010. Atlanta: American Cancer Soc; 2010. Accessed at www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-026238.pdf.on 9 December 2011.
3. El-Serag HB. Epidemiology of hepatocellular carcinoma in USA. Hepatol Res. 2007;37 Suppl 2:S88-94. [PMID: 17877502]
4. Everhart JE. Viral hepatitis. In: Everhart JE, ed. The Burden of Digestive Diseases in the United States. Washington, DC: U.S. Government Printing Office; 2008.
5. Wise M, Bialek S, Finelli L, Bell BP, Sorvillo F. Changing trends in hepatitis C-related mortality in the United States, 1995-2004. Hepatology. 2008;47:1128-35. [PMID: 18318441]
6. Wong JB, McQuillan GM, McHutchison JG, Poynard T. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health. 2000;90:1562-9. [PMID: 11029989]
7. Centers for Disease Control and Prevention. Viral Hepatitis Surveillance- United States, 2009. Accessed at www.cdc.gov/hepatitis/Statistics/2009Surveillance/PDFs/2009HepSurveillanceRpt.pdf on 9 December 2011.
8. Wasley A, Kruszon-Moran D, Kuhnert W, Simard EP, Finelli L, McQuillan G, et al. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis. 2010;202:192-201. [PMID: 20533878]
9. Weinbaum CM, Williams I, Mast EE, Wang SA, Finelli L, Wasley A, et al; Centers for Disease Control and Prevention (CDC). Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep. 2008;57(RR-8):1-20. [PMID: 18802412]
10. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144:705-14. [PMID: 16702586]
11. National Center for Health Statistics. U.S. Standard Death Certificate. Hyattsville, MD: Centers for Disease Control and Prevention; 2003. Accessed at www.cdc.gov/nchs/data/dvs/DEATH11-03final-ACC.pdf on 9 December 2011.
12. National Center for Health Statistics. Physicians' Handbook on Certification of Death, 2003 Revision. DHHS publication no. (PHS) 2003-1108. Hyattsville, MD: Centers for Disease Control and Prevention; 2003. Accessed at www.cdc.gov/nchs/data/misc/hb_cod.pdf on.9.December2011.
13. World Health Organization. International Classification of Diseases, 10th Revision. Geneva: World Health Organization; 1998.
14. Institute for Social Research, University of Michigan. Coded Causes of Death. Ann Arbor: Univ Michigan; 2011. Accessed at http://simba.isr.umich.edu/restricted/docs/Mortality/codedcauses_readfirst.pdf on 9 December 2011.
15. National Center for Health Statistics. Public Use Data Set Documentation: Mortality for ICD-10, 1999. Hyattsville, MD: Centers for Disease Control and Prevention. Accessed at www.cdc.gov/nchs/data/dvs/Mort99doc.pdf on 9 December 2011.
16. Klein RJ, Schoenborn CA. Age adjustment using the 2000 projected U.S. population. Healthy People 2010 Stat Notes. 2001:1-10. [PMID: 11676466]
17. Vogt TM, Wise ME, Shih H, Williams IT. Hepatitis B mortality in the United States, 1990-2004 [Abstract]. In: Final Program and Abstracts of the 45th Annual Meeting of the Infectious Diseases Society of America. Arlington, VA: Infectious Diseases Soc of America; 2007:172.
18. Rein DB, Wittenborn JS, Weinbaum CM, Sabin M, Smith BD, Lesesne SB. Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States. Dig Liver Dis. 2011;43: 66-72. [PMID: 20739252]
19. Koh HK. Viral hepatitis: confronting a silent epidemic. President's Choice Lecture. Presented at the American Association for the Study of Liver Diseases 61st Liver Meeting, Boston, Massachusetts, 31 October 2010.
20. Spradling P, Rupp L, Moorman A, Lu M, Teshale E, Gordon S, et al. Predictors of testing for and infection with hepatitis B virus (HBV) and hepatitis C virus (HCV) in four United States Health Care Organizations (HCOs), 2006-2008 [Abstract]. Presented at 49th Annual Meeting of the Infectious Diseases Society of America, Boston, Massachusetts, 20-23 October 2011.
21. Cohen C, Holmberg SD, McMahon BJ, Block JM, Brosgart CL, Gish RG, et al. Is chronic hepatitis B being undertreated in the United States? J Viral Hepat. 2011;18:377-83. [PMID: 21143343]
22. Denniston MM, Klevens RM, McQuillan GM, Jiles RB. Awareness of infection, knowledge of hepatitis C and medical follow-up among individuals testing positive for hepatitis C: NHANES 2001-2008. Hepatol. 2012. [Forthcoming].
23. Campsmith ML, Rhodes PH, Hall HI, Green TA. Undiagnosed HIV prevalence among adults and adolescents in the United States at the end of 2006. J Acquir Immune Defic Syndr. 2010;53:619-24. [PMID: 19838124]
24. Colvin HM, Mitchell AE, eds; Institute of Medicine. Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. Washington, DC: National Academies Pr; 2010.
25. Seeff LB. The natural history of chronic hepatitis C virus infection. Clin Liver Dis. 1997;1:587-602. [PMID: 15560060]
26. Thomas DL, Seeff LB. Natural history of hepatitis C. Clin Liver Dis. 2005; 9:383-98, vi. [PMID: 16023972]
27. Hahn RA, Wetterhall SF, Gay GA, Harshbarger DS, Burnett CA, Parrish RG, et al. The recording of demographic information on death certificates: a national survey of funeral directors. Public Health Rep. 2002;117:37-43. [PMID: 12297680]
28. Murray CJ, Rajaratnam JK, Marcus J, Laakso T, Lopez AD. What can we conclude from death registration? Improved methods for evaluating completeness. PLoS Med. 2010;7:e1000262. [PMID: 20405002]
29. Adih WK, Selik RM, Xiaohong Hu. Trends in diseases reported on US death certificates that mentioned HIV infection, 1996-2006. J Int Assoc Physicians AIDS Care (Chic). 2011;10:5-11. [PMID: 21088284]
30. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep. 1998;47(RR-19):1-39. [PMID: 9790221]
31. Shehab TM, Orrego M, Chunduri R, Lok AS. Identification and management of hepatitis C patients in primary care clinics. Am J Gastroenterol. 2003; 98:639-44. [PMID: 12650800]
32. Kallman JB, Arsalla A, Park V, Dhungel S, Bhatia P, Haddad D, et al. Screening for hepatitis B, C and non-alcoholic fatty liver disease: a survey of community-based physicians. Aliment Pharmacol Ther. 2009;29:1019-24. [PMID: 19220207]
33. O'Brien SF, Xi G, Yi QL, Goldman M. Understanding non-disclosure of deferrable risk: a study of blood donors with a history of intravenous drug use. Transfus Med. 2010;20:15-21. [PMID: 19793079]
34. El-Kamary SS, Jhaveri R, Shardell MD. All-cause, liver-related, and nonliver-related mortality among HCV-infected individuals in the general US population. Clin Infect Dis. 2011;53:150-7. [PMID: 21665867]
35. Manos MM, Leyden WA, Murphy RC, Terrault NA, Bell BP. Limitations of conventionally derived chronic liver disease mortality rates: Results of a comprehensive assessment. Hepatology. 2008;47:1150-7. [PMID: 18264998]
36. Selik RM, Anderson RN, McKenna MT, Rosenberg HM. Increase in deaths caused by HIV infection due to changes in rules for selecting underlying cause of death. J Acquir Immune Defic Syndr. 2003;32:62-9. [PMID: 12514415]
37. National Center for Health Statistics. Instructions for Classifying the Underlying Cause of Death, ICD-10, 2010. Accessed at www.cdc.gov/nchs/data/ dvs/2A_2010acc.pdf on 4 April 2011.
38. Palella FJ Jr, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, et al; HIV Outpatient Study Investigators. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43:27-34. [PMID: 16878047]
39. U.S. Department of Health and Human Services. Combating the Silent Epidemic of Viral Hepatitis: Action Plan for the Prevention, Care and Treatment of Viral Hepatitis. Washington, DC: U.S. Department of Health and Human Services; 2011.